Polatuzumab Vedotin: How can the Polarix trial help us comprehend DLBCL? Connor Johnson MD Lymphoma 9 Mins Read1 Polatuzumab Vedotin: How can the POLARIX trial help us comprehend DLBCL? Connor Johnson MD By P. Connor Johnson, MD My…
Chimeric Antigen Receptor T-Cell Therapy: A Longitudinal Study Connor Johnson MD Lymphoma 11 Mins Read0 Chimeric Antigen Receptor T-Cell Therapy: A Longitudinal Study Conner Johnson MD By Conner Johnson, MD Chimeric antigen receptor (CAR) T-cell…
